MacDonald J. Christie
MacDonald J. Christie is a cellular and molecular neuropharmacologist with research interests including cellular and molecular mechanisms of opioid receptor signaling in neurons and synapses in pain pathways, the biological basis of adaptations producing chronic pain and drug dependence, and preclinical development of novel pain therapeutics derived from conotoxins. He has published over 160 research papers in the field of neurological sciences, many in top ranked general and discipline-based journals. His published work has received over 6000 citations (H-Index = 42). Christie completed a Ph.D. degree at The University of Sydney in 1983. He was an Australian Postdoctoral Fellow in 1985 (NHMRC), a Fogarty International Fellow at Massachusetts Institute of Technology from 1985 to 1987, and then a Senior Research Associate at the Vollum Institute in Oregon, USA from 1987 to 1990. He was appointed as a Tenured Academic at the Department of Pharmacology, The University of Sydney in 1990, where he was the Head of the department between 1998 and 2000, a Full Professor (personal chair) from 1999, and a Medical Foundation Senior Principal Research Fellow from 1998 to 2002. He has been an NHMRC Senior Principal Research Fellow since 2003. Previously, he served as a Director of Basic Research at the Pain Management Research Institute (University of Sydney 2003–2008) and has been the Director of Neuropharmacology at the Brain & Mind Research Institute, The University of Sydney since 2008. Currently, he is a Chief Investigator on a NH&MRC Program Grant to identify novel pain therapeutics based on conopeptides. Christie presently serves on the editorial boards of several international journals and has served as the Chair of the Scientific Advisory Board of Addiction Neuroscience Network Australia, and an Executive Member of the International Narcotics Research Conference, the peak international opioid research organization.
Biography Updated on 22 June 2009